Skip to main content
. 2019 Jun 24;14:152. doi: 10.1186/s13023-019-1125-2

Fig. 1.

Fig. 1

Presentation of all data entries by neuromuscular centers, genetic institutes and the patient registry, the identification of distinct patients and the allocation to different subtypes of dystrophinopathy (a) or SMA (b)